Skip to main content
. 2017 May;260:47–55. doi: 10.1016/j.atherosclerosis.2017.03.007

Table 1.

FH mutations identified in the study.

Gene DNA:Protein change LDL-C of the carrier (mmol/L) (percentile) TC of the carrier (mmol/L) (percentile) Mutation Predictions
PolyPhen-2 SIFT Mutation Taster
FH mutations
LDLR c.680_681delAC:p.(Asp227Glyfs*12) 6.48(99th) 7.83(99th) Frame shift mutation
c.722T > C:p.(Phe241Ser) 4.47(99th) 5.63(97th) PD NT DC
c.940G > A:p.(Gly314Arg) 2.79(80th) 4.61(72nd) Likely to affect splicing
c.1897C > T:p.(Arg633Cys) 5.36(99th) 7.46(99th) PD NT DC
APOB c.10580G > A:p.(Arg3527Gln) 4.27(99th) 6.38(99th) PD NT DC
4.52(99th) 6.17(99th) PD NT DC

Full characteristics of the variant carriers are shown in Supplementary Table 2.

PD = probably damaging; PsD = possibly damaging; NT = not tolerated; T = tolerated; DC = disease causing; P = polymorphism.